Bioequivalence of HTX-019 (aprepitant IV) and fosaprepitant in healthy subjects: a Phase I, open-label, randomized, two-way crossover evaluation

by Ottoboni, Tom, Keller, Mary Rose, Cravets, Matt, Clendeninn, Neil, Quart, Barry
Published in Drug Des Devel Ther (2018)

Continued inhibition of structural damage over 2 years in patients with rheumatoid arthritis treated with rituximab in combination with methotrexate

by Cohen, Stanley B, Keystone, Edward, Genovese, Mark C, Emery, Paul, Peterfy, Charles, Tak, Paul Peter, Cravets, Matt, Shaw, Tim, Hagerty, David
Published 2010